SCHEMBL963563

SCHEMBL963563

N#CCCNC(=O)c1cccc(-c2cccc(Oc3ccc(Cl)cc3Cl)n2)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 3/20 0.39
HSD17B14 Q9BPX1 1/20 0.36
ATM Q13315 1/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GPR52 Q9Y2T5 1/20 0.35
PPARD Q03181 1/20 0.35
PTGER1 P34995 2/20 0.35
CTSA P10619 1/20 0.35
CNR1 P21554 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
RECQL P46063 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL957949 0.89 GPR52 (0.44) MRGPRX4HSD17B14HPGDALDH1A1GPR52
SCHEMBL961523 0.86 SLC6A2 (0.39) MRGPRX4HPGDNPC1RAB9AALDH1A1
SCHEMBL960377 0.86 P2RX7 (0.40) MRGPRX4ATMHPGDNPC1RAB9A
SCHEMBL962201 0.83 MRGPRX4 (0.53) MRGPRX4HSD17B14HPGDNPC1RAB9A
SCHEMBL959528 0.82 GPR52 (0.45) MRGPRX4ALDH1A1GPR52PPARD
SCHEMBL958740 0.82 KMT2A (0.41) MRGPRX4HPGDNPC1RAB9AALDH1A1
SCHEMBL962542 0.79 KDR (0.43) MRGPRX4NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL959417 0.78 MRGPRX4 (0.46) MRGPRX4HSD17B14ALDH1A1SMN1; SMN2PTGER1
SCHEMBL963502 0.75 GPR52 (0.46) HPGDNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL961939 0.75 GPR52 (0.48) MRGPRX4HPGDSMN1; SMN2GPR52CTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 MRGPRX4 133/4885HSD17B14 2112/4885ATM 3940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.